# Kalia Health

> Kalia Health is a biotech startup building Kal-PDx, a home urine test that screens for preeclampsia the way a pregnancy test screens for a baby - fast, cheap, and without a clinic. Preeclampsia is the second leading cause of maternal death worldwide, and it hits birthing people of color and low-resource regions hardest. Founded out of a Duke global-health class that paired US and Ugandan engineering students, the company is turning a classroom assignment into a point-of-care device aimed at catching the condition before it turns fatal.

- **Founded:** 2018
- **Headquarters:** Chapel Hill, North Carolina, United States
- **Founders:** Denali Dahl (CEO & Co-Founder), Happy Ghosh (Chief Product Officer & Co-Founder), Elizabeth Ndichu (Co-Founder & Clinical Analytics)
- **Team size:** ~5
- **Products:** Kal-PDx, EPED (Early Preeclampsia Detection strip)
- **Notable:** Gates Foundation Grand Challenges grant for early preeclampsia detection (2025), Selected by IndieBio / SOSV, a top early-stage biotech accelerator, Social Justice Innovation Award (2022)

## Products & services

- **Kal-PDx** — A home-based, urine point-of-care test that screens for preeclampsia by detecting elevated protein and urinary biomarkers (including activin A and inhibin A) linked to kidney dysfunction. Designed to work like a home pregnancy test - non-invasive, rapid, low-cost. In development.
- **EPED (Early Preeclampsia Detection strip)** — The earlier lateral-flow strip concept, developed under the founding name Moyo Medical, that became Kal-PDx.

## Achievements

- Gates Foundation Grand Challenges grant for early preeclampsia detection (2025)
- Selected by IndieBio / SOSV, a top early-stage biotech accelerator
- Social Justice Innovation Award (2022)
- Qualcomm Innovator Stipend Program (2022)
- Venture 135 Underrepresented Founder Award (2020)
- Chloe Capital Fellowship (2026)
- Raised equity crowdfunding on StartEngine at a ~$8.99M valuation (2024)

## Latest updates

- **2026-05** — Named a Chloe Capital Fellowship recipient.
- **2025-12** — Awarded a Gates Foundation Grand Challenges grant for a cohort study on urinary biomarkers activin A and inhibin A.
- **2024** — Ran an equity crowdfunding campaign on StartEngine at a roughly $8.99M valuation.
- **2022-09** — Received the Social Justice Innovation Award.

## Links

- Website: https://kaliahealth.com
- LinkedIn: http://www.linkedin.com/company/kalia-health
- Twitter/X: https://twitter.com/KaliaHealth
- Facebook: https://www.facebook.com/KaliaHealth/

---

Profile page: https://yespress.io/kalia-health
Published by YesPress — https://yespress.io
Last updated: 2026-08-19